Project 4-The ability of Circadian Genes in the VTA-Nac circuit to regulate mood
项目4-VTA-Nac回路中昼夜节律基因调节情绪的能力
基本信息
- 批准号:8114144
- 负责人:
- 金额:$ 14.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsAntidepressive AgentsBehaviorBehavioralBehavioral SymptomsBrainCREB1 geneCholecystokininChronicCircadian RhythmsClock proteinEmployee StrikesEvaluationExhibitsExposure toGene ExpressionGene Expression RegulationGene TargetingGenesGoalsHypothalamic structureKnowledgeLightingLithiumManicMediator of activation proteinMental DepressionMolecularMolecular TargetMoodsMotivationMotor ActivityMusMutationNeuronsNucleus AccumbensPatientsPhenotypePlayProteinsRegulationRewardsRoleStressSymptomsTertiary Protein StructureVariantVentral Tegmental AreaViral Vectoremotional stimulusinterestmood regulationresponsesuprachiasmatic nucleustranscription factor
项目摘要
Project 4 focuses on the ability of circadian genes in the ventral tegmental area (VTA)-nucleus accumbens
(NAc) circuit to regulate mood and motivational state. This is related to the knowledge that abnormal mood
and other symptoms in many patients with depression show prominent circadian oscillations. We have
demonstrated that NPAS2 (neuronal PAS domain protein 2), a transcription factor highly homologous to
Clock, regulates an animal's responsiveness to emotional stimuli, including their activity in animal models of
depression. Interestingly, NPAS2 is not expressed in the suprachiasmatic nucleus (SCN), a hypothalamic
region important for circadian oscillations and their entrainment by environmental lighting. Rather, the
highest expression of NPAS2 is seen in the NAc. Our hypothesis is that NPAS2acting within the NAc
contributes to circadian variations in mood, locomotor activity, and motivation. In parallel, we have
established a powerful influence of Clock itself on mood: mice lacking functional Clock protein exhibit a
striking array of behavioral symptoms reminiscent of mania. This phenotype is reversed by lithium, and we
have growing evidence that Clock action in the VTA per se is an important mediator of this behavioral
phenotype.
The goal of the proposed studies is to carry out a systematic evaluation of the role played by NPAS2, Clock,
and related circadian gene products expressed in the VTA and NAc in the regulation of mood and
motivation. This will be accomplished by use of mice with mutations in these various genes and of viral
vectors that selectively manipulate the activity of the genes within the VTA-NAc. In addition, we will further
establish the regulation of circadian gene expression in the VTA and NAc in response to chronic exposure to
stress and antidepressant treatments. As well, we will identify and characterize the target genes through
which NPAS2, Clock, and other circadian genes, acting as transcription factors, regulate the VTA-NAc
circuit. We are also interested in cross talk between these circadian genes and CREB. CREB is known to
regulate certain circadian genes in SCN, and we have found similar regulation in the VTA-NAc. Moreover,
CREB, and circadian transcription factors, share some of the same target genes (e.g., cholecystokinin) in
these brain reward regions.
项目4重点介绍院子腹侧盖区域(VTA) - 舌伏望子的能力
(NAC)调节情绪和动机状态的电路。这与情绪异常的知识有关
许多抑郁症患者的其他症状显示出显着的昼夜节律振荡。我们有
证明了NPAS2(神经元PAS域蛋白2),这是一种与高度同源的转录因子
时钟,调节动物对情绪刺激的反应,包括它们在动物模型中的活动
沮丧。有趣的是,NPAS2在下丘脑(下丘脑)中未表达
区域对于昼夜节律及其在环境照明中的夹带至关重要。而是
NAC中可见NPAS2的最高表达。我们的假设是NPAS2在NAC内作用
有助于情绪,运动活动和动机的昼夜节律变化。并行,我们有
建立了时钟本身对情绪的强大影响:缺乏功能性时钟蛋白的小鼠表现出
引人注目的行为症状让人联想起躁狂症。这种表型被锂逆转,我们
越来越多的证据表明,VTA本身中的时钟动作是这种行为的重要中介者
表型。
拟议的研究的目的是对NPAS2,Clock,
以及在VTA和NAC中表达的相关昼夜节律基因产品,以调节情绪和
动机。这将通过在这些各种基因和病毒中使用突变的小鼠来实现
选择性操纵VTA-NAC中基因活性的载体。此外,我们将进一步
根据长期暴露于VTA和NAC中的昼夜节律基因表达的调节
压力和抗抑郁治疗。同样,我们将通过
NPAS2,时钟和其他充当转录因子的昼夜节律基因调节VTA-NAC
电路。我们也对这些昼夜节律与Creb之间的串扰感兴趣。 Creb已知
调节SCN中的某些昼夜节律基因,我们在VTA-NAC中发现了类似的调节。而且,
CREB和昼夜节律转录因子共享一些相同的靶基因(例如胆囊动蛋白)
这些大脑奖励区域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN L MCKNIGHT其他文献
STEVEN L MCKNIGHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN L MCKNIGHT', 18)}}的其他基金
A solid state conceptualization of information transfer from gene to message to protein
从基因到消息到蛋白质的信息传递的固态概念化
- 批准号:
10083747 - 财政年份:2019
- 资助金额:
$ 14.57万 - 项目类别:
A solid state conceptualization of information transfer from gene to message to protein
从基因到消息到蛋白质的信息传递的固态概念化
- 批准号:
10333328 - 财政年份:2019
- 资助金额:
$ 14.57万 - 项目类别:
A solid state conceptualization of information transfer from gene to message to protein
从基因到消息到蛋白质的信息传递的固态概念化
- 批准号:
10561709 - 财政年份:2019
- 资助金额:
$ 14.57万 - 项目类别:
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
靶向乙酰辅酶A代谢以发现新的抗癌疗法
- 批准号:
9021622 - 财政年份:2014
- 资助金额:
$ 14.57万 - 项目类别:
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
靶向乙酰辅酶A代谢以发现新的抗癌疗法
- 批准号:
8674809 - 财政年份:2014
- 资助金额:
$ 14.57万 - 项目类别:
Reversible Polymerization of Low Complexity Polypeptide Sequences as a Framework
低复杂度多肽序列的可逆聚合作为框架
- 批准号:
8899608 - 财政年份:2014
- 资助金额:
$ 14.57万 - 项目类别:
Discovery, characterization and preclinical development of pro-neurogenic drugs
促神经源性药物的发现、表征和临床前开发
- 批准号:
8461707 - 财政年份:2009
- 资助金额:
$ 14.57万 - 项目类别:
Discovery, characterization and preclinical development of pro-neurogenic drugs
促神经源性药物的发现、表征和临床前开发
- 批准号:
8101261 - 财政年份:2009
- 资助金额:
$ 14.57万 - 项目类别:
Discovery, characterization and preclinical development of pro-neurogenic drugs
促神经源性药物的发现、表征和临床前开发
- 批准号:
7763981 - 财政年份:2009
- 资助金额:
$ 14.57万 - 项目类别:
Discovery, characterization and preclinical development of pro-neurogenic drugs
促神经源性药物的发现、表征和临床前开发
- 批准号:
8305018 - 财政年份:2009
- 资助金额:
$ 14.57万 - 项目类别:
相似国自然基金
乳酸介导的组蛋白乳酸化调控哺乳动物主要合子基因组激活的机制研究
- 批准号:82301880
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带森林土壤氮添加下微节肢动物对氮转化过程的调控
- 批准号:32360323
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Slc39a13在哺乳动物铁代谢中的作用
- 批准号:32371226
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Gene Expression Profiling of Stress Resilient Mice within the Nucleus Accumbens
伏核内应激恢复小鼠的基因表达谱
- 批准号:
10676411 - 财政年份:2023
- 资助金额:
$ 14.57万 - 项目类别:
Estradiol treatment of stress-related psychiatric disorders in Veterans
雌二醇治疗退伍军人压力相关精神疾病
- 批准号:
10484783 - 财政年份:2023
- 资助金额:
$ 14.57万 - 项目类别:
Cellular and circuit mechanisms of the therapeutic action of inhaled nitrous oxide in rodent models of chronic stress
吸入一氧化二氮对慢性应激啮齿动物模型治疗作用的细胞和回路机制
- 批准号:
10712012 - 财政年份:2023
- 资助金额:
$ 14.57万 - 项目类别:
N-acetylserotonin alleviates neurotoxicity in alcohol misuse following TBI
N-乙酰血清素可减轻 TBI 后酒精滥用造成的神经毒性
- 批准号:
10591834 - 财政年份:2023
- 资助金额:
$ 14.57万 - 项目类别:
Determining the role of the primate raphe-habenula circuit in multi-attribute decision-making
确定灵长类动物中缝-缰核回路在多属性决策中的作用
- 批准号:
10464321 - 财政年份:2022
- 资助金额:
$ 14.57万 - 项目类别: